AVENCELL
Based on our deep science and focused on patients in need.
AVENCELL
Social Links:
Industry:
Health Care
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.avencell.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Google Facebook Sharer
Similar Organizations
Ashaeiyn
Ashaeiyn is a Spiritual Awakening and Pure Consciousness Meditation Center.
Grand Round Table
Help doctors solve difficult cases
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
InterVene
InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
RxMx
Connecting cutting-edge therapies with patients
Syllable
Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Official Site Inspections
http://www.avencell.com Semrush global rank: 15.1 M Semrush visits lastest month: 18
- Host name: 16.110.212.35.bc.googleusercontent.com
- IP address: 35.212.110.16
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "AvenCell"
Clinical-stage biopharma company targets hard-to-treat cancers
Andrea is the Vice President of Finance and Corporate Controller for AvenCell where she brings over 20 years of experience to AvenCell’s US finance and accounting operations. Prior to …See details»
AvenCell - Crunchbase Company Profile & Funding
Organization. AvenCell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Based on our deep science and focused on …See details»
AvenCell - LinkedIn
AvenCell | 3,211 followers on LinkedIn. Next generation immunotherapies | Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat ...See details»
AvenCell - Leadership Team - The Org
The Leadership Team at AvenCell drives the company’s strategic vision and oversees the implementation of its modular antibody complex technology. Comprising executives from …See details»
AvenCell 2025 Company Profile: Valuation, Funding & Investors
AvenCell General Information Description. Developer of T cell-based immunotherapies intended to support cancer treatment. The company focuses on building chimeric antigen receptor T …See details»
AvenCell Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
2 days ago About AvenCell Therapeutics AvenCell derives its name from the French word "avenir" to reflect the aim to be the FUTURE of cell therapy. AvenCell is building a truly …See details»
Org Chart AvenCell Therapeutics - The Official Board
Nov 11, 2024 Organizational Chart of AvenCell Therapeutics. AvenCell Therapeutics avencell.com. has 15 executives +1 617 941 7468; Add an executive. AvenCell Therapeutics …See details»
Novo Holdings · Investments · avencell
Novo Holdings A/S. Tuborg Havnevej 19. 2900 Hellerup Denmark +45 3527 6500 . Email: [email protected] CVR# 24257630See details»
Careers - AvenCell
Careers We intend to be at the forefront of an ongoing revolution in hematology and oncology where life-threatening hard-to-treat cancers are combated by using the patient’s own immune system. Working at AvenCell Our teams are …See details»
AvenCell - VentureRadar
AvenCell’s mission is to overcome the limitations of current-generation CAR-T cell therapies with an improved therapeutic window and substantially expand the types of cancer treatable with …See details»
AvenCell - Contacts, Employees, Board Members, Advisors & Alumni
Organization. AvenCell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
AvenCell – Funding, Valuation, Investors, News
AvenCell Therapeutics is on the rise. The Watertown, MA-based company has just secured $112 million in Series B funding. This financial boost is a game-changer. It promises to accelerate …See details»
AvenCell - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 22, 2024: Series B - …See details»
Company: AvenCell
AvenCell brings together switchable universal T-cell technology developed by the former Cellex subsidiary GEMoaB GmbH, with a license to Intellia Therapeutics proprietary CRISPR-Cas9 …See details»
☑️AvenCell Europe GmbH — Consulting Organization from …
Dec 6, 2024 AvenCell Europe GmbH — Consulting Organization from Germany with 11-50 employees, has experience with Horizon Europe (2021 - 2027), it`s involved in Health, …See details»
AvenCell Europe GmbH - Drug pipelines, Patents, Clinical trials
2 days ago Explore AvenCell Europe GmbH with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 25 news, and 12 literature, Disease Domain:Neoplasms, Hemic and …See details»
Switchable, adaptable, allogeneic next generation ... - AvenCell
Prior to joining Avencell, Susan had multiple senior level roles within the Biotech, Pharmaceutical and CRO organizations. Susan has experience in leading clinical operations teams to …See details»
AvenCell Company Overview, Contact Details & Competitors
Oct 22, 2024 Immunotherapy Innovations AvenCell is focused on developing next-generation immunotherapies for hard-to-treat cancers, making them a potential partner for hospitals, …See details»
Global health tech company Omnicell to open innovation lab in …
1 day ago The World Health Organization has estimated a shortfall of about 4.5 million nurses and 310,000 midwives by 2030. In the U.S., researchers believe that 1.2 million new …See details»
AvenCell’s broad pre-clinical and clinical pipeline
AvenCell has a broad pipeline of product candidates in preclinical and clinical development for the treatment of hematologic malignancies as well as solid tumors. Our lead clinical program is …See details»